Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer

ISSN: 2211-5544 (Online)
ISSN: 2211-5552 (Print)

Volume 4, 2 Issues, 2015

Download PDF Flyer

Current Molecular Imaging (Discontinued)

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Abass Alavi
Department of Radiology/Nuclear Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA 19104

View Full Editorial Board

Purchase Articles Order Reprints

Application of Radiolabeled Antibodies in Targeting Therapy of Breast Cancer

Current Molecular Imaging (Discontinued), 2(2): 120-129.

Author(s): Zahra Heidari, Mojtaba Salouti and Reyhaneh Sariri.

Affiliation: Moallem Street, Etemadieh, Zanjan Branch, Islamic Azad University, Zanjan, Iran.


Breast cancer continues to be the second-leading cause of cancer in world. Early detection, improved surgical techniques, and more effective therapy methods have improved quality of life and survival for patients, particularly those with less advanced diseases. Therefore, tremendous amounts of time and efforts are dedicated to search toward earlier detection and more efficient treatment of breast cancer. Advances in molecular cancer biology achieved an increased understanding of the biologic factors that contribute to breast cancer pathogenesis and progression. This understanding has already led to more effective treatment. Among different therapy modalities, nuclear medicine provides an important role to the clinical management of breast cancer. In this review, the history of radioimmunotherapy of breast cancer as a targeted molecular method is reviewed.


Breast cancer, targeted molecular therapy, radiolabeled antibodies, radioimmunotherapy.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 2
Issue Number: 2
First Page: 120
Last Page: 129
Page Count: 10
DOI: 10.2174/2211555211302020003
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science